Effect of UGT2B7 genotypes on plasma concentration of valproic acid: a meta-analysis

[1] Göttlicher M(2004)Valproic acid: an old drug newly discovered as inhibitor of histone deacetylases Ann Hematol 83 S91-S92

[2] Jawień W(2017)Population pharmacokinetic modelling of valproic acid and its selected metabolites in acute VPA poisoning Pharmacol Rep 69 340-349

[3] Wilimowska J(1984)Aspects of the metabolism of valproic acid Xenobiotica 14 375-387

[4] Kłys M(2017)Association of CYP2C9, CYP2A6, ACSM2A, and CPT1A gene polymorphisms with adverse effects of valproic acid in Chinese patients with epilepsy Epilepsy Res 132 64-69

[5] Piekoszewski W(2012)Effects of UGT1A6, UGT2B7, and CYP2C9 genotypes on plasma concentrations of valproic acid in Chinese children with epilepsy Drug Metab Pharmacokinet 27 536-542

[6] Granneman GR(1993)Substrate specificities of two stably expressed human liver UDP-glucuronosyltransferases of the UGT1 gene family Drug Metab Dispos 21 50-55

[7] Wang SI(2016)Association of UGT2B7 and UGT1A4 polymorphisms with serum concentration of antiepileptic drugs in children Med Sci Monit 22 4107-4113

[8] Machinist JM(2011)Association of genetic variants in six candidate genes with valproic acid therapy optimization Pharmacogenomics 12 1107-1117

[9] Kesterson JW(1998)The glucuronidation of opioids, other xenobiotics, and androgens by human UGT2B7Y (268) and UGT2B7H (268) Drug Metab Dispos 26 73-77

[10] Wang C(2006)Haplotype analysis of UDP-glucuronocyltransferase 2B7 gene (UGT2B7) polymorphisms in healthy Japanese subjects Clin Biochem 39 303-308

[1] Göttlicher M(2004)Valproic acid: an old drug newly discovered as inhibitor of histone deacetylases Ann Hematol 83 S91-S92

[2] Jawień W(2017)Population pharmacokinetic modelling of valproic acid and its selected metabolites in acute VPA poisoning Pharmacol Rep 69 340-349

[3] Wilimowska J(1984)Aspects of the metabolism of valproic acid Xenobiotica 14 375-387

[4] Kłys M(2017)Association of CYP2C9, CYP2A6, ACSM2A, and CPT1A gene polymorphisms with adverse effects of valproic acid in Chinese patients with epilepsy Epilepsy Res 132 64-69

[5] Piekoszewski W(2012)Effects of UGT1A6, UGT2B7, and CYP2C9 genotypes on plasma concentrations of valproic acid in Chinese children with epilepsy Drug Metab Pharmacokinet 27 536-542

[6] Granneman GR(1993)Substrate specificities of two stably expressed human liver UDP-glucuronosyltransferases of the UGT1 gene family Drug Metab Dispos 21 50-55

[7] Wang SI(2016)Association of UGT2B7 and UGT1A4 polymorphisms with serum concentration of antiepileptic drugs in children Med Sci Monit 22 4107-4113

[8] Machinist JM(2011)Association of genetic variants in six candidate genes with valproic acid therapy optimization Pharmacogenomics 12 1107-1117

[9] Kesterson JW(1998)The glucuronidation of opioids, other xenobiotics, and androgens by human UGT2B7Y (268) and UGT2B7H (268) Drug Metab Dispos 26 73-77

[10] Wang C(2006)Haplotype analysis of UDP-glucuronocyltransferase 2B7 gene (UGT2B7) polymorphisms in healthy Japanese subjects Clin Biochem 39 303-308